Single-Dose Nipah, Hendra Vaccine for Humans Effective 7 Days After Immunization
Newswise Bethesda, MD A vaccine for use against the deadly Nipah and Hendra viruses has demonstrated effectiveness in preclinical studies as early as 7 days following a single immunization, according to a new study, A Single Dose Investigational Subunit Vaccine for Human Use against Nipah virus and Hendra virus, published in the journal,
npj Vaccines, online February 8, 2021.
A collaborative group of investigators from the Uniformed Services University (USU), the University of Texas Medical Branch (UTMB) and Galveston National Laboratory (GNL), and Profectus BioSciences, Inc. (now Auro Vaccines LLC), carried out two preclinical studies of a Nipah and Hendra virus vaccine. Their results show that a subunit vaccine formulated for use in humans is effective as early as a week after the vaccination is administered.
The coronavirus is rapidly changing. This Fargo startup zeroes in on mutations and vaccine response
Biomed Protection has an online analytical tool to evaluate a vaccine s effectiveness against coronavirus mutations, which could help vaccine makers respond to the rapidly changing virus. The firm also is testing some of its own vaccine candidates that could be developed in North Dakota. Written By: Patrick Springer | ×
Isabelle Chambers is involved in developing a platform to detect mutations in the coronavirus that will help develop a vaccine for COVID-19. The effort has a $1.4 million grant from the state of North Dakota and could ramp up with manufacturing at Aldevron. David Samson / The Forum
GALVESTON Even after much of the general population gets COVID-19 vaccines, they will likely need to get annual doses to protect against future mutations of the virus, according to researchers at the University of Texas Medical Branch at Galveston. Scott Weaver, director of the medical branch’s infectious disease research programs, said viruses like COVID-19 will eventually find ways to mutate in order to continue to infect people, even those.